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ABSTRACT* 
Pharmacists have an important role in detecting, 
preventing, and solving prescription problems, 
which if left unresolved, may pose a risk of harming 
the patient.  
Objective: The objectives of this study were to 
evaluate the feasibility of a generic study instrument 
for documentation of prescription problems requiring 
contact with prescriber before dispensing. The study 
was organized: 1) by countries: Estonia, Norway 
and Sweden; 2) by type of prescriptions: 
handwritten prescriptions, printouts of prescriptions 
in the electronic medical record and electronically 
transmitted prescriptions to pharmacies; and 3) by 
recording method - self-completion by pharmacists 
and independent observers. 
Methods: Observational study with independent 
observers at community pharmacies in Estonia 
(n=4) and Sweden (n=7) and self-completed 
protocols in Norway (n=9). 
Results: Pharmacists’ in Estonia contacted the 
prescriber for 1.47% of the prescriptions, about 3 
times as often as in Norway (0.45%) and Sweden 
(0.38%). Handwritten prescriptions dominated 
among the problem prescriptions in Estonia 
(73.2%), printouts of prescriptions in the electronic 
medical record (89.1%) in Norway and electronically 
transmitted prescriptions to pharmacies (55.9%) in 
Sweden. 
More administrative errors were identified on 
handwritten prescriptions and printouts of 
prescriptions in the electronic medical record in 
Estonia and in Norway compared with electronically 
transmitted prescriptions to pharmacies in Sweden 
(p<0.05 for prescription types and p<0.01 for 
countries). However, clinically important errors and 
delivery problems appeared equally often on the 
different types of prescriptions. In all three 
countries, only few cases of drug interactions and 
adverse drug reactions were identified. 
Conclusion: Despite the different patterns of 
prescription problems in three countries, the 
instrument was feasible and can be regarded 
appropriate to document and classify prescription 
problems necessitating contact with prescriber 
before dispensing, irrespective of the type of 
prescription or recording method. 
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USO DE UN PROTOCOLO GENÉRICO EN 
LA DOCUMENTACIÓN DE LOS ERRORES 
DE PRESCRIPCIÓN EN ESTONIA, 
NORUEGA Y SUECIA 
 
RESUMEN 
Los farmacéuticos juegan un papel importante en la 
detección, prevención y resolución de problemas de 
prescripción, que si no se resuelven pueden poner 
en riesgo de daño al paciente. 
Objetivo: Los objetivos de este estudio fueron 
evaluar la factibilidad de un instrumento de 
genérico de estudio para documentar los problemas 
de prescripción que requieren contactar al 
prescriptor antes de dispensar. El estudio se 
organizó: 1) por países: Estonia, Noruega y Suecia; 
2) por tipo de recetas: recetas manuscritas, recetas 
impresas desde el historial electrónico del médico, 
y prescripción electrónica; y 3) por método de 
registro: auto-cumplimentación por los 
farmacéuticos o por observadores independientes. 
Métodos: Estudio observacional con observadores 
independientes en las farmacias comunitarias en 
Estonia (n=4) y Suecia (n=7) y protocolos auto-
cumplimentados en Noruega (n=9). 
Resultados: Los farmacéuticos en Estonia 
contactaron a los prescriptores en el 1.47% de las 
recetas, unas 3 veces más frecuentemente que en 
Noruega (0.45%) y Suecia (0.38%).Las recetas 
manuscritas dominaron entre los problemas de 
prescripción en Estonia (73.2%), las impresiones de 
recetas desde el historial electrónico (89.1%) en 
Noruega, y las prescripciones electrónicamente 
transmitidas a las farmacias (55.9%) en Suecia. 
Se identificaron más errores administrativos en las 
recetas manuscritas y en las impresas desde el 
historial electrónico en Estonia y Noruega, 
comparadas con las electrónicamente transmitidas a 
la farmacia de Suecia (p<0.05 para los tipos de 
recetas y p<0.01 para los países). Sin embargo, los 
errores clínicamente importantes y los problemas 
de entrega aparecieron igualmente entre los 
diferentes tipos de recetas. En los tres países, se 
identificaron unos pocos casos de interacciones 
medicamentosas y de reacciones adversas. 
Conclusión: A pesar de los tres patrones diferentes 
de prescripción en los tres países, el instrumento 
fue factible y puede considerarse apropiado para 
documentar y clasificar los problemas de 
prescripción que necesitan contactar con el 
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prescriptor antes de ser dispensados, 
independientemente del tipo de receta o del método 
de registro. 
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INTRODUCTION 
Prescribing errors are defined as prescribing 
decision or mistakes in the prescription writing 
process that result in unintentional significant 
reduction in the probability of timely and effective 
treatment or an increase in the risk of harm. 
Prescribing errors are a common cause for 
preventable medication errors and adverse drug 
events in primary care.1 Frequent occurring 
prescription errors include incorrect selection of 
medication for the patient including the dose, 
quantity, indication, or the prescribing a 
contraindicated medication.2 
Community pharmacists have an important role in 
detecting, preventing, and solving prescription 
problems, which if left unresolved, may pose a risk 
of harming the patient.3 Pharmacists intervene to 
eliminate or minimize these risks, often by 
contacting the prescriber with suggestions to 
change the medication.4 In studies that have judged 
the clinical importance of pharmacists’ actions, it 
was found that their actions were clinically relevant 
and approved by the prescribers in most cases.5-8 
However, the recorded rates of prescription 
problems at pharmacies are composed of 
prescription error rates, detection rates, and actions 
taken, as well as recording rates. Detection and 
action rates by pharmacists are influenced by 
pharmacy size, location, organization of work and 
work load of the pharmacy9 and available 
information concerning patient and prescribed 
medication.10 
Prescription error rates may vary with prescribers, 
licensing examination scores, medical speciality, 
experience, practice group structure and culture, 
and the number of doctors involved in prescribing to 
the patient. Error rates may also vary with the 
design of the prescription form and how the 
prescription is generated (handwritten prescription, 
prescriptions produced in the electronic medical 
record and electronically transmitted prescriptions to 
pharmacies).11-15 Error rates are higher with 
handwritten prescriptions, where ambiguous 
instructions and interpretation errors and 
administrative errors, such as missing prescriber or 
patient data, may constitute a large part of the 
recorded prescription problems.11 
Pharmacists’ detection, recording, and action rates 
of prescription errors are influenced by pharmacy 
size, location, organization, workload, available 
information (such as presence on the prescription of 
indication or intended use), access to patient record 
or patient medication profile, attendance of the 
patient or a representative at the pharmacy to have 
the prescription dispensed, and the individual 
pharmacists’ education and training. 
Recording rates may vary with recording method 
and appropriateness and feasibility of recording 
instruments used. Different instruments have been 
used in different studies, but few of them have been 
evaluated. Some may have been developed for 
classification of prescription problems in the context 
of handwritten prescriptions, others for use in situ in 
a specific local context or study. Furthermore, in a 
context where mainly printouts of prescriptions in 
the electronic medical record and electronically 
transmitted prescriptions to pharmacies are used, 
previous classifications may be obsolete, and the 
error pattern may have changed. Errors commonly 
encountered with handwritten prescriptions may 
have resolved but new clinically significant errors 
such as incorrect drug selection, may have been 
introduced.16,17 
Estonia, Norway and Sweden differ in their 
organization of health care and the community 
pharmacy sector.18-20 Detailed information 
concerning operation of community pharmacies and 
drug prescribing systems is presented in Table 1. 
The objective of the study was to evaluate the 
feasibility of a generic instrument to document 
prescription problems requiring contact with 
prescriber before dispensing. The study was 
organized: (1) by countries: Estonia, Norway and 
Sweden; (2) by type of prescriptions: handwritten 
prescriptions, printouts of prescriptions in the 
electronic medical record and electronically 
transmitted prescription to pharmacies and (3) by 
recording method - self-completed by pharmacists 
or recording by independent observers. 
 
METHODS  
In Norway the protocol was self-completed by 
dispensing pharmacists at 9 community pharmacies 
located in the western and eastern regions of the 
country. The study was undertaken over the course 
of 5 weeks, 25 weekdays per pharmacy in 
September and October 2004.21 
In Estonia, the protocol was completed by 
independent observers (trained pharmacy 
students). Data were collected over a period of 6 
weeks and 30 weekdays per pharmacy in January, 
July and September 2006. Four community 
pharmacies located near GP centres or in 
ambulatory clinics in 3 larger cities participated in 
the study.22 
In Sweden the protocol was used in a study with 7 
community pharmacies in large cities in the middle 
and northern part of country.17 The protocol was 
completed by independent observers (trained 
pharmacy students) over the course of three 
consecutive weeks, 15 weekdays, per pharmacy 
from February 2007 to February 2008. 
The protocol and form, originally developed in the 
USA, has been translated and adapted to the 
Scandinavian context by one of the authors 
(SH).21,23 The Estonian translation was piloted for 3 
days at one community pharmacies that later 
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participated in the study. The Swedish version was 
piloted by independent observers in a pre-study at 4 
community pharmacies for 2 weeks per pharmacy. 
One author in each country scrutinised the 
protocols. Classification problems and irregularities 
in classification were discussed with the observers 
for consensus and consistency.  
Prescriptions on medications to humans with errors, 
ambiguities or other problems, where the 
pharmacist judged it necessary to contact the 
prescriber for clarification, correction, completion or 
change before dispensing were included in the 
study. All attempts to contact the prescribers were 
recorded whether or not they resulted in an actual 
contact. 
The prescription problems were categorised as: 
1. Administrative errors – technical errors 
concerning information about the prescriber or 
the patient, missing or erroneous date, 
reimbursement issues; 
2.  Problems with clinical significance – 
inappropriate medication or indication; 
inappropriate strength, dose or administration 
form of medication; adverse drug reactions or 
drug-drug interactions; insufficient information 
concerning use of medication (instruction for 
use, quantity, duration of treatment);  
3.  Other problem – mostly those involving delivery 
– prescription of an unlicensed medication; 
unavailability of the licensed medication on the 
market, out of stock at the wholesaler or at the 
pharmacy. 
Categorisation of the prescription problems was 
initially performed by one of the authors (AE) and 
was reviewed and discussed with the other authors 
(SH) and (DV).  
The initial analysis of the data was performed in a 
spread sheet (Microsoft Excel®). For statistical 
analysis program Statistical Package for Social 
Sciences (SPSS, Version 11.0, Chicago, IL) was 
used. Two-way Anova was used to calculate the 
probability of incidence of different types of errors 
with different type of prescription and context 
(Estonia, Norway, Sweden). Type of prescription 
error was used as dependent variable, prescription 
type and country were used as fixed factors. Post 
hoc tests were used to perform detailed analysis for 
prescription error, country and prescription type. 
The statistical significance level was set to P≤0.05. 
 
RESULTS  
For 732 (0.51%) of all dispensed prescriptions, 194 
(1.47%) in Estonia, 311 (0.45%) in Norway and 229 
(0.38%) in Sweden, the pharmacists judged it 
necessary to contact the prescriber for clarification 
before dispensing.  
About 80% of the problem prescriptions were new 
prescriptions. There was statistically significant 
difference (p<0.001) in the types of prescriptions 
requiring contact with prescriber between Estonia, 
Norway and Sweden. Handwritten prescriptions 
constituted 73.2% in Estonia, 10.9% in Norway and 
9.2% in Sweden. In Norway, the majority of the 
problem prescriptions were printouts of 
prescriptions in the electronic medical record and in 
Sweden more than half of the prescriptions were 
electronically transmitted prescriptions to 
pharmacies (Table 2).  
There were statistically significant differences 
between the countries for problems with selection of 
medication or incorrect indication [F(2)=7.979; 
p<0.001), and dosage schedule (F(2)=5.333; 
p<0.001). For problems with incorrect medication or 
Table 1. Operation of community pharmacies and prescribing systems of medicinal products in Estonia, Norway and 
Sweden 
Country Estonia Norway Sweden (at the time of the 
study) 
Population (01.01.2011) 1 340 100 4 920 305 9 428 100 
Number of community 
pharmacies (2011) 
510 
One pharmacy per 2627 
inhabitants 
~700 
One pharmacy per 7000 
inhabitants 
~900 
One pharmacy per 10.500 
inhabitants 
Ownership of community 
pharmacies  
Private, ~85% in 
pharmacy chains or 
working in cooperation 
with chains 
Private,  in pharmacy 
chains or working in 
cooperation with chains 
(32 public sector hospital 
pharmacies)  
At the time of the study all 
pharmacies were owned 
by the government and 
part of the National 
corporation of Swedish 
Pharmacies 
Computer software used at 
community pharmacies 
2-3 different types, 
available for not only chain 
pharmacies 
All pharmacies use 
FarmaPro program 
At the time of the study all 
pharmacies used the same 
soft-ware 
E-prescription Since 2010 Since 2011 Since 1983; >85 % of all 
new prescriptions at the 
time of the study 
Telephone and fax prescriptions No Yes Yes 
Printed prescriptions Yes, primary and 
secondary care 
Yes, primary and 
secondary care 
Yes 
Handwritten prescriptions Yes, to some extent in 
secondary care 
Yes Yes 
Legal prescription form Yes Yes Yes 
Use of electronic medical record 
of patient by prescriber 
Yes Yes Yes 
Access to electronic medical 
record of patient at pharmacy 
No No No 
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indication, the post hoc analysis revealed 
statistically significant differences between a) 
Estonia and Norway, and b) Estonia and Sweden 
(p<0.01). There were also differences for `dosage 
schedule problems` between a) Estonia and 
Sweden, and b) Norway and Sweden. Although not 
statistically significant, there was a trend that 
clinically important errors were more common with 
electronically transmitted prescriptions compared 
with printouts of prescriptions in the electronic 
medical record printouts and handwritten 
prescriptions. 
Estonia had the highest incidence of administrative 
errors due to the high proportion of handwritten 
prescriptions (Table 3). Statistically significant 
correlations were observed between missing 
information about the patient and a) prescription 
type (F(2)=6.326; p<0.01) and b) country 
(F(2)=7.679; p<0.01). Post hoc analysis 
demonstrated statistically significant differences for 
handwritten prescriptions, printouts of prescriptions 
in the electronic medical record and electronically 
transmitted prescriptions to pharmacies (p<0.001), 
between a) Estonia and Norway (p=0.01) and b) 
Estonia and Sweden (p<0.001).  
Delivery problems were common in all three 
countries (Table 3).  
There was statistically significant difference in 
successful contact of the pharmacists with 
prescriber in Estonia, Norway and Sweden 
(p<0.05). The pharmacist did not succeed to reach 
the prescriber for 15 (7.8%) of the cases in Estonia, 
71 (22.8%) in Norway and 63 (27.5%) in Sweden. In 
Estonia the most common outcome was “no 
dispensing of the drug” (4 cases) or “dispensed as 
prescribed” (5 cases). In Sweden, contact with 
another physician, with a nurse at the ward/surgery, 
with a secretary or making a different intervention 
constituted 1/4th each of these instances. In 
Norway, for 39 (54.9%) cases the prescription was 
changed and dispensed and the prescriber was 
contacted afterwards. 
When the pharmacists contacted the prescriber, the 
pharmacist`s suggestions were approved by the 
prescriber in 68.8% of the cases in Estonia, 69.1% 
in Norway and 67.0% in Sweden. 
 
DISCUSSION 
Several independent studies using different 
protocols have documented the detection of 
prescription problems by community pharmacists 
and their interventions to solve them.5,7-9,11 As far as 
the authors of this article know this is the first 
international study using a generic study instrument 
to identify the patterns and magnitude of 
prescription errors in different contexts. 
Table 2. Description of prescriptions that required contact with the prescriber before dispensing 
 Estonia (n=4) 
Norway 
(n=9) 
Sweden 
(n=7) 
Dispensed prescriptions 13,221 69,315 59,901 
Contact with prescriber before dispensing 194 (1.47%) 
311 
(0.45%) 
229 
(0.38%) 
Handwritten prescriptions 142 (73.2%) 
31 
(10.0%) 17 (7.4%) 
Printouts of prescriptions written in the electronic medical record-
printouts 
52 
(26.8%) 
273 
(87.8%) 
77 
(33.6%) 
Electronically transmitted prescription - - 128 (55.9%) 
Prescription is not classified as handwritten prescriptions, printouts 
of prescriptions written in the electronic medical record, 
electronically transmitted prescription 
 6 (1.9%) 7 (3.1%) 
Table 3. Distribution of prescription errors by country (number of problem prescriptions) 
Estonia (n=194 ) Norway (n=311) Sweden (n=229) Two-way Anova  n % n % n % F(df) P 
Incorrect medication 73 38.7 131 42.1 106 46.3   
Incorrect medication/indication 
Incorrect strength of medication 
Incorrect administration form 
Treatment period/number of doses 
Contraindication 
Drug-drug interaction 
ADR/toxicity 
6 
32 
10 
17 
2 
5 
3 
3.1 
16.5 
5.2 
8.8 
1.0 
2.6 
1.5 
42 
35 
10 
38 
2 
4 
- 
13.5 
11.3 
3.2 
12.2 
0.6 
1.3 
- 
55 
13 
20 
13 
2 
3 
- 
24.0 
5.7 
8.7 
5.7 
0.9 
1.3 
- 
F(2)=7.979 
F(2)=1.485 
F(2)=0.327 
F(2)=0.785 
NA 
NA 
NA 
p<0.001 
NS 
NS 
NS 
NA 
NA 
NA 
Delivery problems 29 14.9 43 13.8 45 19.7 NA NS 
Schedule/instructions for use 24 12.4 76 24.4 65 28.4   
Schedule 
Instructions for use 
13 
11 
6.7 
5.7 
39 
37 
12.5 
11.9 
60 
5 
26.2 
  2.2 
F(2)=5.333 
F(2)=2.864 
p<0.01 
NS 
Administrative errors 96 49.5 121 38.9 21 9.2   
Patient 
Wrong patient 
Prescriber 
Reimbursement of price of medication 
30 
- 
42 
24 
15.5 
- 
21.6 
12.4 
19 
3 
44 
55 
6.1 
1.0 
14.1 
17.7 
2 
1 
2 
16 
0.9 
0.4 
0.9 
7.0 
F(2)=6.326 
NA 
F(2)=7.679 
F(2)=0.375 
p<0.01 
NA 
p<0.01 
NS 
Total (errors) 222  371  237    
Errors per prescription 1.1  1.1  1.0    
NA - not applicable 
NS - not significant 
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The study instrument was comprehensive with 
respect to recording different types of prescription 
errors or omissions (including adaptation to record 
new problems and errors associated with printouts 
of prescriptions written in the electronic medical 
record and electronically transmitted prescriptions), 
actions taken by the pharmacist and the outcome. 
The study instrument in this study could be used in 
everyday practice at community pharmacies for self-
completion of recording of prescription problems or 
for research purposes to evaluate more complex 
questions.  
The pattern of prescription errors with potential 
clinical hazards varied by country, but appeared to 
be similar with all types of prescriptions. However 
this is not confirmed by other studies.14,24,25 
In the current study, only few cases of drug-drug 
interactions were detected, contrasting the results in 
studies using prescription databases.26,27 The 
difference may to some extent depend on that in 
Estonia and Sweden pharmacists at the time of the 
study had access to patients´ pharmacy record for 
identification of possible interactions between the 
new prescription medications and those dispensed 
previously. In Belgium, pharmacists could access 
patients´ records and this increased their 
professional independence in handling prescription 
errors, a result supported by the other studies.28 
The incidence of administrative errors was directly 
associated with how the prescriptions were 
generated similar to the findings in other 
studies.29,30 In Estonia and Norway, electronically 
transmitted prescription had not been introduced at 
the time of the study, and the number of 
administrative errors was higher than in Sweden, 
with a high proportion of electronically transmitted 
prescription.  
The generic instrument used has not been validated 
against any standard as the authors did not find any 
standards to use. However, the classification was 
validated by different means in consensus 
discussions in all three countries.  
It should be emphasized that problems in the study 
only represent a fraction of all prescription 
problems. The current selection of problem 
prescriptions can be explained by desire to focus on 
problems in the content of the prescription, rather 
than administrative or technical errors.  
It was not possible to calculate the relative 
incidence of problem prescriptions for handwritten 
prescriptions, printouts of prescriptions written in the 
electronic medical record-printouts and 
electronically transmitted prescriptions, as 
dispensing data are not available for the different 
prescription types. However, the classification of 
different prescription types was undertaken only for 
the purposes of the current study; by the study 
observers in Estonia for all problem prescriptions 
identified during the study period and in Norway and 
Sweden for problem prescription requiring contact 
with the prescriber. 
Moreover, the data collection and the protocol was 
used in different modes - self-completed in Norway 
and independent observers in Estonia and Sweden 
- why the results may not be totally comparable. 
However, the differences in the number of recorded 
prescription problems are associated with 
prescription type rather than recording method. It is 
also reasonable to assume that adherence to the 
self-reporting protocol decreases in periods of high 
work-load compared to studies performed by an 
independent observer.31 Moreover, the participating 
pharmacies were not randomly selected and may 
thus not be representative for all pharmacies within 
each country. 
The studies in three countries were also undertaken 
in different years. However, it was more important to 
find a period in which no major reforms were taking 
place in the community pharmacy sector or drug 
prescribing system than to undertake parallel 
studies.  
The objective was to evaluate the feasibility of using 
a generic instrument for documentation and 
classification of problem prescriptions in different 
contexts, not to compare the incidence of 
prescription errors. The presented results illustrate 
more the feasibility of the generic protocol to 
document and classify prescription problems. The 
presented data should not be generalized to 
problem incidence in the individual countries. 
 
CONCLUSIONS 
The generic protocol was shown to be appropriate 
and feasible to document prescription problems in 
different contexts involving country, prescription 
type, the pattern and number of prescription 
problems and recording methods. The study 
revealed differences in the pattern and number of 
prescription problems in Estonia, Norway and 
Sweden. The number of problem prescriptions was 
three times higher in Estonia compared with Norway 
and Sweden, mainly because of the high frequency 
of handwritten prescriptions. Electronically 
transmitted prescription to pharmacies may reduce 
the total number of prescribing errors – e.g. 
administrative errors as well as errors of clinical 
importance, but may also introduce new clinically 
important errors, such as selection of inappropriate 
medication. 
Some aspects of health care system organization 
(type of prescription, pharmacists´ access to 
patients´ medical record) may have direct impact on 
the content, number and handling of prescription 
problems. Access to the patients´ medical record 
could increase the detection of possible adverse 
drug reactions and drug-drug interactions. 
 
CONFLICT OF INTEREST 
All authors declare that they have no conflicts of 
interest relevant to the subject of the manuscript.  
No external sources of funding were sought or 
obtained to conduct this study. 
 
Volmer D, Haavik S, Ekedahl A. Use of a generic protocol in documentation of prescription errors in Estonia, Norway 
and Sweden. Pharmacy Practice (Internet) 2012 Apr-Jun;10(2):72-77. 
www.pharmacypractice.org (ISSN: 1886-3655) 77
References 
 
1. Dean B, Barber N, Schachter M. What is a prescribing error? Qual Health Care. 2000;9(4):232–237.  
2. Kuo GM, Phillips RL, Graham D, Hickner JM. Medication errors reported by US family physicians and their office staff. 
Qual Saf Health Care. 2008;17(4):286-290. 
3. Council of Europe. Creation of a better medication safety culture in Europe: Building up safe medication practices. 
Expert Group on Safe Medication Practices (P-SP-PH-SAFE) (2006). Available from 
http://www.coe.int/t/e/social_cohesion/soc-sp/Medication%20safety%20culture%20report%20E.pdf (Accessed April 14, 
2011). 
4. Baciu A, Stratton K, Burke SP, eds. The Future of Drug Safety. Promoting and Protecting the Health of the Public. 
Washington: The National Academies Press; 2007.  
5. Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during 
the dispensing process. Br J Clin Pharmacol. 1999;47(6):695-700. 
6. Buurma H, De Smet PA, Leufkens HG, Egberts AC. Evaluation of the clinical value of pharmacists’ modifications of 
prescription errors. Br J Clin Pharmacol. 2004;58(5):503-511. 
7. Claesson C, Burman K, Nilsson JLG, Vinge E. Prescription errors detected by Swedish pharmacists. Int J Pharm Pract. 
1995;3,151-156.  
8. Hulls V, Emmerton L. Prescription interventions in New Zealand community practice. J Soc Admin Pharm 1996;13:198-
204. 
9. Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. 
Med Care. 1992;30(10):926-940. 
10. Benrimoj SI, Langford JH, Berry G, Collins D, Lauchlan R, Stewart K, Aristides M, Dobson M. Economic impact of 
increased clinical intervention rates in community pharmacy. A randomised trial of the effect of education and a 
professional allowance. Pharmacoeconomics. 2000;18(5):459-468. 
11. Buurma H, de Smet PA, van den Hoff OP, Egberts AC. Nature, frequency and determinants of prescription 
modifications in Dutch community pharmacies. Br J Clin Pharmacol. 2001;52(1):85-91. 
12. Shah NH, Aslam M, Avery AJ. A survey of prescription errors in general practice. Pharm J 2001;(267):860-862. 
13. Westein MP, Herings RM, Leufkens HG. Determinants of pharmacists’ interventions linked to prescription processing. 
Pharm World Sci. 2001;23(3):98-101. 
14. Varkey P, Aponte P, Swanton C, Fischer D, Johnson SF, Brennan MD. The effect of computerized physician-order entry 
on outpatient prescription errors. Manag Care Interface. 2007;20(3):53-57. 
15. Gil de San Vicente O, Erauncetamurgil O, de Escalza P, Odriozola I, Gastelurrutia MA. Assessment of poorly written 
prescriptions that reach a community pharmacy. Seguimiento Farmacoterapeutico 2005;3(3);125-129. 
16. Astrand B, Montelius E, Petersson G, Ekedahl A. Assessment of ePrescription quality: an observational study at three 
mail-order pharmacies. BMC Med Inform Decis Mak. 2009;9:8.  
17. Ekedahl A. Problem prescriptions in Sweden necessitating contact with the prescriber before dispensing. Res Social 
Adm Pharm. 2010;6(3):174-184.  
18. Westerlund LT, Björk HT. Pharmaceutical Care in Community Pharmacies: Practice and Research in Sweden. Ann 
Pharmacother. 2006;40(6):1162-1169. 
19. Almarsdottir AB, Traulsen JM. Multimethod research into policy change in the pharmacy sector – The Nordic case. Res 
Social Adm Pharm. 2009;5(1):82-90.  
20. Volmer D, Vendla K, Vetka A, Bell JS, Hamilton D. Pharmaceutical care in community pharmacies: practice and 
research in Estonia. Ann Pharmacother. 2008;42(7):1104-1111.  
21. Haavik S, Horn AM, Mellbye KS, Kjønniksen I, Granås AG. Forskrivningsfeil - omfang og oppklaring. Tidsskr Nor 
Laegeforen. 2006 26;126(3):296-298. 
22. Volmer D, Haavik S, Ekedahl A, Veski P. Probleemsed retseptid, mille alusel ravimi väljastamine apteegist nõuab 
konsultatsiooni ravimi ordineerijaga Eesti, Norra ja Rootsi võrdlusuuringu põhjal. Eesti Arst. 2010;89,5−12. 
23. Kennedy AG, Littenberg B. A modified outpatient prescription form to reduce prescription errors. Jt Comm J Qual Saf. 
2004;30(9):480-487. 
24. Oliven A, Michalake I, Zalman D, Dorman E, Yeshurun D, Odeh M. Prevention of prescription errors by computerized, 
on-line surveillance of drug order entry. Int J Med Inform. 2005;74(5):377-386.  
25. Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, Strom BL. Role of computerized physician order 
entry systems in facilitating medication errors. JAMA. 2005;293(10):1197-1203.  
26. Astrand B, Astrand E, Antonov K, Petersson G. Detection of potential drug interactions - a model for a national 
pharmacy register. Eur J Clin Pharmacol. 2006;62(9):749-756.  
27. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study 
of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007;30(10):911-918.  
28. Leemans L, Veroeveren L, Bulens J, Hendrickx C, Keyenberg W, Niesten F, Vandeberg J, Van Hoof J, Laekeman G. 
Frequency and trends of interventions of prescriptions in Flemish community pharmacies. Pharm World Sci. 
2003;25(2):65-69. 
29. Lynskey D, Haigh SJ, Patel N, Macadam AB. Medication errors in community pharmacy: an investigation into the types 
and potential causes. Int J Pharm Pract 2007;15(2):105-112. 
30. Bizovi KE, Beckley BE, McDade MC, Adams AL, Lowe RA, Zechnich AD, Hedges JR. The effect of computer-assisted 
prescription writing on emergency department prescription errors. Acad Emerg Med. 2002;9(11):1168-1175.  
31. Mandt I, Horn AM, Ekedahl A, Granas AG. Community pharmacists' prescription intervention practices—Exploring 
variations in practice in Norwegian pharmacies. Res Social Adm Pharm. 2010;6(1):6-17. 
